The tool is designed to provide easy access to data on the characteristics and suitability of the available boosted PIs as potential components of regimens for treatment-experienced patients, using data from prescribing information, clinical studies, and the expert opinion of the author, Joseph J. Eron, Jr, MD

An Interactive Decision Support Tool and Video Resource

A comprehensive guide to neurologic complications directly related to HIV infection of the central nervous system or to opportunistic diseases and neoplasms resulting from immune dysfunction. Browse the complications by name, or search them by presenting symptoms. Includes extensive video clips illustrating components of the neurologic examination, and classic presentations of specific complications.

Considering the efficacy, safety, and tolerability factors in determining the appropriate antiretroviral components for your patient’s initial HAART regimen?

This tool enables you to review data from controlled studies on the DHHS and IAS-USA preferred antiretroviral regimens for initial antiretroviral therapy. You can also view a convenient graphical summary of the key data from those studies and print the data and/or download corresponding slides.

Understanding the potential for dyslipidemia or other cardiovascular risk factors while determining an appropriate HAART regimen

This tool enables you to review data from controlled studies on the lipid effects of recommended antiretroviral regimens for initial therapy as well as ‘switch strategies’ in patients on suppressive antiretroviral therapy.

You can also view a convenient graphical summary of the key data from those studies and print the data and/or download corresponding slides.

Considering switching a virologically suppressive antiretroviral regimen and want to know the key data associated with the specific switch?

This tool enables you to select specific switches that have been evaluated in controlled studies and then view a convenient graphical summary of the key data from those studies. You can also print the data and/or download slides.

This interactive tool is intended to help the user assess the characteristics of different NRTI backbones, according to criteria that have been selected for their potential relevance in specific clinical settings.

This interactive tool allows you to explore the balance between the potential benefits and cardiovascular risks of antiretroviral therapy in the background of various patient and treatment-related risk factors.

An interactive resource that illustrates the impact of different interventions on the 10-year risk of cardiovascular disease in hypothetical patients with different baseline characteristics.

An interactive flowchart offering options for the clinical care of HIV-infected patients who experience protease inhibitor-associated hyperlipidemia.